Editas Medicine EDIT Earnings Call Transcripts

NASDAQ EDIT
$2.38 -0.13 (-4.99%)
At close: Nov 11, 2026 · 4:00 PM EST
9 earnings calls on file for Editas Medicine, from Q4 2019 to Q2 2024. Each transcript opens in a new tab.
Latest earnings call

Editas Medicine Q2 2024 Earnings Call

Aug 7, 2024 7,810 words · 34 min read
  • Gilmore O’NeillChief Executive Officer
  • Baisong MeiChief Medical Officer
  • Erick LuceraChief Financial Officer
  • Linda BurklyChief Scientific Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Editas Medicine Earnings Call Transcripts

Calls9
LatestAug 7, 2024
SinceQ4 2019

Fiscal 2024

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 9 Editas Medicine transcripts Register to get access to Editas Medicine’s earnings call transcripts.